www.tillotts.com

IN THIS ISSUE

Conference on Drug Delivery in Reims 2015: In April, 2 posters were presented during the 1st European Conference on Pharmaceutics - Drug Delivery in Reims, France.

We take care of our waste: Waste has also a high priority at Tillotts. An overview regarding amount, handling and development.

Interview: André Schneider, HSE Specialist.

ww

w.tillotts.com

T: +41 61 935 28 28 F: +41 61 935 28 29 E: services@tillotts.com

For more information, please contact us at:

Tillotts Pharma AGTillotts Services, Hauptstrasse 274417 Ziefen, Switzerland

Follow us on LinkedIn:Please join our LinkedIn Group “Tillotts Services” on LinkedIn. We will inform you about several forthcoming events as well as the latest news within Tillotts Services.

See us on YouTube:If you are interested in the Liquid Fill Encapsulation Technology as well as in the manufacturing process of Tillotts Services you have now the opportunity to follow us on YouTube.

NEWSLETTERIn this edition Karin Strübin interviews André Schneider, HSE Specialist

INT

ER

VIE

W

Issue 14

Let’s Have Coffee..

André, please tell us a little about yourselfI live in Lauwil – a small village with 330 residents, 8 minutes from Ziefen by car – with my wife and my children (my son Tim, 10 and my daughter Mia, 8½). I grew up with 2 brothers and my sister (Sonja Dubach-Schneider who also works at Tillotts) on a farm in the hills of Lauwil. In my spare time I prefer to be outdoors in nature, more or less actively, I also like to work creatively with wood or relax reading a book or listening to music.

When did you join Tillotts?I joined Tillotts on the 2nd of June, 1997 working full time as an operations electrician. After my first child was born, I reduced my workload at Tillotts to 80%. Since July 2013 I have been working 50%, predominantly as a safety inspector

What is your role within Tillotts?As an operations electrician I was responsible for the maintenance of the electric installations, calibrations in the plant and for the maintenance of the building utilities.

As a safety inspector I am responsible for the development and realization of the safety organization. I identify the risks regarding health and safety at work and together with the heads of the departments I develop the necessary actions. I register remaining risks and observe any accidents occurring. In this way I can identify the needs for training and preventive measures.

I also continue to support the engineering department regarding the maintenance of the scales and the locking system here in Ziefen. Furthermore, I maintain the plant surroundings as a balance for my mental work.

Of what project are you proudest?There is not “the project” I am proud of. There are the many small achievements: When I succeeded in getting a machine to run again or when ideas created at my desk, then really worked in practice.

What will be your next major challenge in Tillotts?Detaching myself from former responsibilities of my previous function.

What was the biggest challenge for you at Tillotts up to now?The change from the “family company”, where everyone knows everybody, where everybody is always very flexible and helpful, where everybody brings his own meat to the barbecue – to a multicultural company with complex structures, language barriers and the distance due to different locations.

The support and the flexibility in our team and in the company enables me to plan my work at the company and at home, as well as my family life and leisure time in an optimal way. I am very thankful for this.

Your own question or what I always wanted to say…

13 - 15 October 2015 CPhI/ICSE Madrid, Spain http://www.cphi.com

For more information please visit:

Tillotts Services will be represented at the following events during 2015. We would be delighted to meet with you.

The conference was a great opportunity to learn about current state-of-the-art drug delivery approaches for small and large molecules as well as for networking with leading experts in formulation, drug targeting and drug delivery. The solid scientific program included presentations by Prof. Patrick Couvreur (Paris, France), Prof. Hartmut Derendorf, Gainesville (FL, USA) and Prof. David Brayden from the University of Dublin (Ireland). Moreover, more than 300 posters were presented in areas such as advanced drug delivery systems for proteins and gen delivery, controlled drug delivery and bioavailability as well as absorption enhancement.

Conference on Drug Delivery

Scientists from all over the world, working in research and development of drug products and medical devices, scale-up and/or production attended this meeting to discuss hot topics like:

• Drug Targeting • Drug Delivery Systems • Liposomes and Nanoparticles • Formulation Development

As experts in the oral formulation of poorly soluble active pharmaceutical ingredients (APIs) and in coating technologies, as well as drug delivery systems for targeted delivery of the APIs in the colon, we presented two scientific posters in collaboration with the following academic institutions: The University of Applied Sciences and Arts Northwestern Switzerland (FHNW), the University of Basel and our business collaboration partner Qualicaps.

Reims, France April 13th - 14th

Roberto Bravo, Head of Pharmaceutical Development, and Claudio Scialdone, Senior Manager Contract Services and Business Development attended the 1st European Conference on Pharmaceutics Drug Delivery in Reims (France).

See inside for details of our poster presentations.

Copyright ©Tillotts Pharma AG 2015Colpermin is a registered trademark owned by Tillotts Pharma AG except in the UK and Ireland. www.tillotts.com

Taking care of our waste and our responsibility for the environmentAs you can imagine, quite a bit of waste accumulates in a production company, even ours. We make sure as little waste as possible accrues and of course that it is disposed of in accordance with the regulations.

For more information on the Posters please contact Roberto Bravo or Claudio Scialdone

Photo - From the left: Roberto Bravo, Susana Ecenarro Probst (Qualicaps Europe, Head of Business Development), Gabriela Dujovny (Qualicaps Europe, Director R&D Business Development), Alexandra Machado (postgraduate scientist, FHNW), Tohru Kokubo (Qualicaps Japan, Manager Capsule Research & Development Department)

Photo - From the left: Daniel Preisig (PhD Student Uni Basel /Tillotts Pharma), Roberto Bravo and Claudio Scialdone

Poster presentation by our postgraduate scientist Alexandra Machado from the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) resulting from the research collaboration between Qualicaps Europe and Tillotts Pharma AG (Tillotts Services).

Poster presentation by our PhD student Daniel Preisig. Collaboration with the University of Basel (Department of Pharmaceutical Sciences), Switzerland. Research project funded by the Swiss Commission of Technology and Innovation (CTI) and Tillotts Pharma AG.

“Molecular water interaction in lipid-based formulations and capsule compatibility”

“Development of muco-adhesive drug delivery systems by precipitation of chitosan on drug-loaded microparticles”

Conference on Drug Delivery, Reims 2015Poster presentations:

Annual comparison of the waste volumes in Ziefen (kg)

Most of the waste, 12.01 t consists of

cardboard and paper and 6.4 t is household rubbish. These then already account for 45% of the total amount of waste

from Ziefen.

In 2014 a total of 41.819 t of all

kinds of waste were disposed of, 40.45 t of which accumulated

in Ziefen.

We are happy to be able to inform

you that the annual ‘development’ of

waste quantities is negative. Within 5 years it has been reduced by 18%, which makes us

proud!

Copyright ©Tillotts Pharma AG 2015Colpermin is a registered trademark owned by Tillotts Pharma AG except in the UK and Ireland. www.tillotts.com

Taking care of our waste and our responsibility for the environmentAs you can imagine, quite a bit of waste accumulates in a production company, even ours. We make sure as little waste as possible accrues and of course that it is disposed of in accordance with the regulations.

For more information on the Posters please contact Roberto Bravo or Claudio Scialdone

Photo - From the left: Roberto Bravo, Susana Ecenarro Probst (Qualicaps Europe, Head of Business Development), Gabriela Dujovny (Qualicaps Europe, Director R&D Business Development), Alexandra Machado (postgraduate scientist, FHNW), Tohru Kokubo (Qualicaps Japan, Manager Capsule Research & Development Department)

Photo - From the left: Daniel Preisig (PhD Student Uni Basel /Tillotts Pharma), Roberto Bravo and Claudio Scialdone

Poster presentation by our postgraduate scientist Alexandra Machado from the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) resulting from the research collaboration between Qualicaps Europe and Tillotts Pharma AG (Tillotts Services).

Poster presentation by our PhD student Daniel Preisig. Collaboration with the University of Basel (Department of Pharmaceutical Sciences), Switzerland. Research project funded by the Swiss Commission of Technology and Innovation (CTI) and Tillotts Pharma AG.

“Molecular water interaction in lipid-based formulations and capsule compatibility”

“Development of muco-adhesive drug delivery systems by precipitation of chitosan on drug-loaded microparticles”

Conference on Drug Delivery, Reims 2015Poster presentations:

Annual comparison of the waste volumes in Ziefen (kg)

Most of the waste, 12.01 t consists of

cardboard and paper and 6.4 t is household rubbish. These then already account for 45% of the total amount of waste

from Ziefen.

In 2014 a total of 41.819 t of all

kinds of waste were disposed of, 40.45 t of which accumulated

in Ziefen.

We are happy to be able to inform

you that the annual ‘development’ of

waste quantities is negative. Within 5 years it has been reduced by 18%, which makes us

proud!

www.tillotts.com

IN THIS ISSUE

Conference on Drug Delivery in Reims 2015: In April, 2 posters were presented during the 1st European Conference on Pharmaceutics - Drug Delivery in Reims, France.

We take care of our waste: Waste has also a high priority at Tillotts. An overview regarding amount, handling and development.

Interview: André Schneider, HSE Specialist.

ww

w.tillotts.com

T: +41 61 935 28 28 F: +41 61 935 28 29 E: services@tillotts.com

For more information, please contact us at:

Tillotts Pharma AGTillotts Services, Hauptstrasse 274417 Ziefen, Switzerland

Follow us on LinkedIn:Please join our LinkedIn Group “Tillotts Services” on LinkedIn. We will inform you about several forthcoming events as well as the latest news within Tillotts Services.

See us on YouTube:If you are interested in the Liquid Fill Encapsulation Technology as well as in the manufacturing process of Tillotts Services you have now the opportunity to follow us on YouTube.

NEWSLETTERIn this edition Karin Strübin interviews André Schneider, HSE Specialist

INT

ER

VIE

W

Issue 14

Let’s Have Coffee..

André, please tell us a little about yourselfI live in Lauwil – a small village with 330 residents, 8 minutes from Ziefen by car – with my wife and my children (my son Tim, 10 and my daughter Mia, 8½). I grew up with 2 brothers and my sister (Sonja Dubach-Schneider who also works at Tillotts) on a farm in the hills of Lauwil. In my spare time I prefer to be outdoors in nature, more or less actively, I also like to work creatively with wood or relax reading a book or listening to music.

When did you join Tillotts?I joined Tillotts on the 2nd of June, 1997 working full time as an operations electrician. After my first child was born, I reduced my workload at Tillotts to 80%. Since July 2013 I have been working 50%, predominantly as a safety inspector

What is your role within Tillotts?As an operations electrician I was responsible for the maintenance of the electric installations, calibrations in the plant and for the maintenance of the building utilities.

As a safety inspector I am responsible for the development and realization of the safety organization. I identify the risks regarding health and safety at work and together with the heads of the departments I develop the necessary actions. I register remaining risks and observe any accidents occurring. In this way I can identify the needs for training and preventive measures.

I also continue to support the engineering department regarding the maintenance of the scales and the locking system here in Ziefen. Furthermore, I maintain the plant surroundings as a balance for my mental work.

Of what project are you proudest?There is not “the project” I am proud of. There are the many small achievements: When I succeeded in getting a machine to run again or when ideas created at my desk, then really worked in practice.

What will be your next major challenge in Tillotts?Detaching myself from former responsibilities of my previous function.

What was the biggest challenge for you at Tillotts up to now?The change from the “family company”, where everyone knows everybody, where everybody is always very flexible and helpful, where everybody brings his own meat to the barbecue – to a multicultural company with complex structures, language barriers and the distance due to different locations.

The support and the flexibility in our team and in the company enables me to plan my work at the company and at home, as well as my family life and leisure time in an optimal way. I am very thankful for this.

Your own question or what I always wanted to say…

13 - 15 October 2015 CPhI/ICSE Madrid, Spain http://www.cphi.com

For more information please visit:

Tillotts Services will be represented at the following events during 2015. We would be delighted to meet with you.

The conference was a great opportunity to learn about current state-of-the-art drug delivery approaches for small and large molecules as well as for networking with leading experts in formulation, drug targeting and drug delivery. The solid scientific program included presentations by Prof. Patrick Couvreur (Paris, France), Prof. Hartmut Derendorf, Gainesville (FL, USA) and Prof. David Brayden from the University of Dublin (Ireland). Moreover, more than 300 posters were presented in areas such as advanced drug delivery systems for proteins and gen delivery, controlled drug delivery and bioavailability as well as absorption enhancement.

Conference on Drug Delivery

Scientists from all over the world, working in research and development of drug products and medical devices, scale-up and/or production attended this meeting to discuss hot topics like:

• Drug Targeting • Drug Delivery Systems • Liposomes and Nanoparticles • Formulation Development

As experts in the oral formulation of poorly soluble active pharmaceutical ingredients (APIs) and in coating technologies, as well as drug delivery systems for targeted delivery of the APIs in the colon, we presented two scientific posters in collaboration with the following academic institutions: The University of Applied Sciences and Arts Northwestern Switzerland (FHNW), the University of Basel and our business collaboration partner Qualicaps.

Reims, France April 13th - 14th

Roberto Bravo, Head of Pharmaceutical Development, and Claudio Scialdone, Senior Manager Contract Services and Business Development attended the 1st European Conference on Pharmaceutics Drug Delivery in Reims (France).

See inside for details of our poster presentations.